{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:18:29Z","timestamp":1792718309490,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T00:00:00Z","timestamp":1588377600000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA172447"],"award-info":[{"award-number":["R01 CA172447"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA033572"],"award-info":[{"award-number":["P30CA033572"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Stem Cell"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.stem.2019.02.018","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T10:43:53Z","timestamp":1553165033000},"page":"769-784.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":178,"title":["Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells"],"prefix":"10.1016","volume":"24","author":[{"given":"Puneet","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Isringhausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Gomariz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"Nombela-Arrieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.stem.2019.02.018_bib1","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/labinvest.2014.110","article-title":"CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes","volume":"94","author":"Abe-Suzuki","year":"2014","journal-title":"Lab. Invest."},{"key":"10.1016\/j.stem.2019.02.018_bib2","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1038\/leu.2017.82","article-title":"The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a\/16-1 expression","volume":"31","author":"Abraham","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.stem.2019.02.018_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nature15250","article-title":"Deep imaging of bone marrow shows non-dividing stem cells are mainly perisinusoidal","volume":"526","author":"Acar","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.stem.2019.02.018_bib4","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1182\/blood-2016-05-714089","article-title":"Enhanced targeting of CML stem and progenitor cells by inhibition of porcupine acyltransferase in combination with TKI","volume":"129","author":"Agarwal","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.stem.2019.02.018_bib5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq--a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.stem.2019.02.018_bib6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature13383","article-title":"Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms","volume":"512","author":"Arranz","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.stem.2019.02.018_bib7","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ncb3475","article-title":"Differential cytokine contributions of perivascular haematopoietic stem cell niches","volume":"19","author":"Asada","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.stem.2019.02.018_bib8","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1182\/blood-2008-10-186668","article-title":"CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy","volume":"113","author":"Azab","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.stem.2019.02.018_bib9","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3389\/fimmu.2016.00666","article-title":"Pro-inflammatory-related loss of CXCL12 niche promotes acute lymphoblastic leukemic progression at the expense of normal lymphopoiesis","volume":"7","author":"Balandr\u00e1n","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.stem.2019.02.018_bib10","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood-2015-06-653113","article-title":"Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome","volume":"127","author":"Balderman","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.stem.2019.02.018_bib11","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1158\/1535-7163.MCT-13-0410","article-title":"Combination of imatinib with CXCR4 antagonist BKT140 overcomes the protective effect of stroma and targets CML in\u00a0vitro and in\u00a0vivo","volume":"13","author":"Beider","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.stem.2019.02.018_bib12","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1182\/blood.V85.12.3636.bloodjournal85123636","article-title":"Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages","volume":"85","author":"Bhatia","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.stem.2019.02.018_bib13","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2002-09-2780","article-title":"Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment","volume":"101","author":"Bhatia","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.stem.2019.02.018_bib14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/nyas.13016","article-title":"Niche heterogeneity in the bone marrow","volume":"1370","author":"Birbrair","year":"2016","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/j.stem.2019.02.018_bib15","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1182\/blood-2014-06-582924","article-title":"Osteoblast ablation reduces normal long-term hematopoietic stem cell self-renewal but accelerates leukemia development","volume":"125","author":"Bowers","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.stem.2019.02.018_bib16","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/nm.3707","article-title":"Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion","volume":"20","author":"Bruns","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.stem.2019.02.018_bib17","doi-asserted-by":"crossref","first-page":"351ra105","DOI":"10.1126\/scitranslmed.aae0501","article-title":"Hematopoietic stem cell transplantation in immunocompetent hosts without radiation or chemotherapy","volume":"8","author":"Chhabra","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.stem.2019.02.018_bib18","first-page":"248","article-title":"Targeting the CXCL12\/CXCR4 axis in acute myeloid leukemia: from bench to bedside","volume":"32","author":"Cho","year":"2017","journal-title":"Korean J. Intern. Med. (Korean. Assoc. Intern. Med.)"},{"key":"10.1016\/j.stem.2019.02.018_bib19","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1182\/blood-2010-12-327437","article-title":"Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment","volume":"118","author":"Chu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.stem.2019.02.018_bib20","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.stem.2019.02.018_bib21","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1080\/10428190903150847","article-title":"Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+ cell to imatinib and nilotinib","volume":"50","author":"Dillmann","year":"2009","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.stem.2019.02.018_bib22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature11885","article-title":"Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches","volume":"495","author":"Ding","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.stem.2019.02.018_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.stem.2019.02.018_bib24","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/labinvest.2012.93","article-title":"Distinctive contact between CD34+ hematopoietic progenitors and CXCL12+ CD271+ mesenchymal stromal cells in benign and myelodysplastic bone marrow","volume":"92","author":"Flores-Figueroa","year":"2012","journal-title":"Lab. Invest."},{"key":"10.1016\/j.stem.2019.02.018_bib25","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3324\/haematol.2016.163436","article-title":"Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia","volume":"102","author":"Gleixner","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.stem.2019.02.018_bib26","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1038\/s41467-018-04770-z","article-title":"Quantitative spatial analysis of haematopoiesis-regulating stromal cells in the bone marrow microenvironment by 3D microscopy","volume":"9","author":"Gomariz","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stem.2019.02.018_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bone.2014.02.018","article-title":"Consequences of irradiation on bone and marrow phenotypes, and its relation to disruption of hematopoietic precursors","volume":"63","author":"Green","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.stem.2019.02.018_bib28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature11926","article-title":"CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance","volume":"495","author":"Greenbaum","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.stem.2019.02.018_bib29","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2010-12-326843","article-title":"Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival","volume":"119","author":"Hamilton","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.stem.2019.02.018_bib30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.stem.2014.06.020","article-title":"Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche","volume":"15","author":"Hanoun","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2019.02.018_bib31","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.stem.2012.08.001","article-title":"Ezh1 is required for hematopoietic stem cell maintenance and prevents senescence-like cell cycle arrest","volume":"11","author":"Hidalgo","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2019.02.018_bib32","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1146\/annurev-pathol-012615-044414","article-title":"Hematopoietic stem cell niche in health and disease","volume":"11","author":"Hoggatt","year":"2016","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.stem.2019.02.018_bib33","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1158\/0008-5472.CAN-06-2014","article-title":"Growth factor stimulation reduces residual quiescent chronic myelogenous leukemia progenitors remaining after imatinib treatment","volume":"67","author":"Holtz","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.stem.2019.02.018_bib34","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1158\/1078-0432.CCR-05-0429","article-title":"Intermittent exposure of primitive quiescent chronic myeloid leukemia cells to granulocyte-colony stimulating factor in\u00a0vitro promotes their elimination by imatinib mesylate","volume":"12","author":"J\u00f8rgensen","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.stem.2019.02.018_bib35","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1182\/blood-2005-09-3585","article-title":"The polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion","volume":"107","author":"Kamminga","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.stem.2019.02.018_bib36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.semcancer.2017.07.006","article-title":"Epigenetic dysregulation in chronic myeloid leukaemia: a myriad of mechanisms and therapeutic options","volume":"51","author":"Koschmieder","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.stem.2019.02.018_bib37","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1182\/blood-2003-12-4369","article-title":"Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis","volume":"105","author":"Koschmieder","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.stem.2019.02.018_bib38","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/nm.3364","article-title":"Differential regulation of myeloid leukemias by the bone marrow microenvironment","volume":"19","author":"Krause","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.stem.2019.02.018_bib39","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/leu.2017.259","article-title":"Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion","volume":"32","author":"Kumar","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.stem.2019.02.018_bib40","first-page":"1245","article-title":"Bone marrow angiogenesis: methods of quantification and changes evolving in chronic myeloproliferative disorders","volume":"19","author":"Kvasnicka","year":"2004","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.stem.2019.02.018_bib41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40164-016-0050-5","article-title":"Effectiveness of AMD3100 in treatment of leukemia and solid tumors: from original discovery to use in current clinical practice","volume":"5","author":"Liu","year":"2016","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.stem.2019.02.018_bib42","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.stem.2019.02.018_bib43","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/leu.2013.288","article-title":"EZH2 in normal and malignant hematopoiesis","volume":"28","author":"Lund","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.stem.2019.02.018_bib44","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.molcel.2008.11.004","article-title":"Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms","volume":"32","author":"Margueron","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.stem.2019.02.018_bib45","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1084\/jem.20161418","article-title":"Niche-mediated depletion of the normal hematopoietic stem cell reservoir by Flt3-ITD-induced myeloproliferation","volume":"214","author":"Mead","year":"2017","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.stem.2019.02.018_bib46","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1182\/blood-2016-11-696070","article-title":"The microenvironment in human myeloid malignancies: emerging concepts and therapeutic implications","volume":"129","author":"Medyouf","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.stem.2019.02.018_bib47","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12984","article-title":"The bone marrow niche for haematopoietic stem cells","volume":"505","author":"Morrison","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.stem.2019.02.018_bib48","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature08734","article-title":"TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia","volume":"463","author":"Naka","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.stem.2019.02.018_bib49","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/MCB.06148-11","article-title":"Myc regulates the transcription of the PRC2 gene to control the expression of developmental genes in embryonic stem cells","volume":"32","author":"Neri","year":"2012","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.stem.2019.02.018_bib50","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.1182\/blood-2008-06-162123","article-title":"Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100","volume":"113","author":"Nervi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.stem.2019.02.018_bib51","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1182\/bloodadvances.2016003194","article-title":"Quantification and three-dimensional microanatomical organization of the bone marrow","volume":"1","author":"Nombela-Arrieta","year":"2017","journal-title":"Blood Adv."},{"key":"10.1016\/j.stem.2019.02.018_bib52","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/ncb2730","article-title":"Quantitative imaging of haematopoietic stem and progenitor cell localization and hypoxic status in the bone marrow microenvironment","volume":"15","author":"Nombela-Arrieta","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.stem.2019.02.018_bib53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.immuni.2010.08.017","article-title":"The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche","volume":"33","author":"Omatsu","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.stem.2019.02.018_bib54","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1182\/blood-2016-08-737239","article-title":"IL-4\/CXCL12 loop is a key regulator of lymphoid stroma function in follicular lymphoma","volume":"129","author":"Pandey","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.stem.2019.02.018_bib55","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1634\/stemcells.20-3-259","article-title":"Immature leukemic CD34+CXCR4+ cells from CML patients have lower integrin-dependent migration and adhesion in response to the chemokine SDF-1","volume":"20","author":"Peled","year":"2002","journal-title":"Stem Cells"},{"key":"10.1016\/j.stem.2019.02.018_bib56","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1172\/JCI43605","article-title":"BCR-ABL kinase is dead; long live the CML stem cell","volume":"121","author":"Perl","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.stem.2019.02.018_bib57","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1084\/jem.20122252","article-title":"PDGFR\u03b1 and CD51 mark human nestin+ sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion","volume":"210","author":"Pinho","year":"2013","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.stem.2019.02.018_bib58","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ccell.2015.05.002","article-title":"CXCL12-producing vascular endothelial niches control acute T\u00a0cell leukemia maintenance","volume":"27","author":"Pitt","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.stem.2019.02.018_bib59","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ccr.2011.10.012","article-title":"IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development","volume":"20","author":"Reynaud","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.stem.2019.02.018_bib60","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.stem.2017.03.008","article-title":"Gli1+ mesenchymal stromal cells are a key driver of bone marrow fibrosis and an important cellular therapeutic target","volume":"20","author":"Schneider","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2019.02.018_bib61","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/2159-8290.CD-16-0263","article-title":"Epigenetic reprogramming sensitizes CML stem cells to combined EZH2 and tyrosine kinase inhibition","volume":"6","author":"Scott","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.stem.2019.02.018_bib62","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.immuni.2006.10.016","article-title":"Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches","volume":"25","author":"Sugiyama","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.stem.2019.02.018_bib63","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.immuni.2004.05.001","article-title":"Cellular niches controlling B lymphocyte behavior within bone marrow during development","volume":"20","author":"Tokoyoda","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.stem.2019.02.018_bib64","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1182\/blood-2013-02-485573","article-title":"JAK of all trades: JAK2-STAT5 as novel therapeutic targets in BCR-ABL1+ chronic myeloid leukemia","volume":"122","author":"Warsch","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.stem.2019.02.018_bib65","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/leu.2011.360","article-title":"Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib","volume":"26","author":"Weisberg","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.stem.2019.02.018_bib66","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1158\/2159-8290.CD-15-1439","article-title":"Chronic myelogenous leukemia- initiating cells require polycomb group protein EZH2","volume":"6","author":"Xie","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.stem.2019.02.018_bib67","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ccr.2012.02.018","article-title":"Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia","volume":"21","author":"Zhang","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.stem.2019.02.018_bib68","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/blood-2012-02-412890","article-title":"Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-\u03b2-catenin signaling","volume":"121","author":"Zhang","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.stem.2019.02.018_bib69","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1182\/blood-2015-11-679928","article-title":"Inhibition of interleukin-1 signaling enhances elimination of tyrosine kinase inhibitor-treated CML stem cells","volume":"128","author":"Zhang","year":"2016","journal-title":"Blood"}],"updated-by":[{"DOI":"10.1016\/j.stem.2019.11.013","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000}}],"container-title":["Cell Stem Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934590919300700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934590919300700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:47:58Z","timestamp":1761832078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1934590919300700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1934590919300700"],"URL":"https:\/\/doi.org\/10.1016\/j.stem.2019.02.018","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735369803.793583307","asserted-by":"object"}]},"ISSN":["1934-5909"],"issn-type":[{"value":"1934-5909","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells","name":"articletitle","label":"Article Title"},{"value":"Cell Stem Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.stem.2019.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}